Autonomix (AMIX) CEO Bradley Hauser Receives 27,000-Share Award

What Happened

• Bradley Hauser, CEO and President of Autonomix Medical, received a grant/award of 27,000 restricted shares on September 3, 2026. The filing reports no purchase price (N/A) because this was an equity award, not an open-market transaction. The award is reported as transaction code “A” (award/grant).

Key Details

• Transaction date: September 3, 2026; Form 4 filed September 8, 2026. (Filing shows calendar delay of five days; timeliness label not provided in the supplied data.)
• Shares involved: 27,000 restricted shares; price: N/A (award).
• Vesting/conditions: Per footnote, the restricted stock award vests one year from issuance (vesting date Sept 3, 2027).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: F1 — award vests one year from issuance (Sept 3, 2026).

Context

• This was an equity compensation award (not a purchase or sale). Restricted shares typically cannot be sold until vesting, so this is a retention/compensation event rather than an immediate market vote by the insider.
• For investors, grants can signal management retention incentives but do not directly indicate near-term insider buying or selling.